Seeking Alpha

ATHX

Athersys, Inc.

5/27/2012, 3:00 PM ET

Business Intelligence
Transcripts
Events
Key Developments

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

171 people get ATHX articles and Market Currents by email alert.

Get email alerts on ATHX »

ATHX Market Currents more »

May 11 Premarket gainers: ARNA +93%. GV +45.5%. ATHX +15%. AVG +12%. ZOOM +9%. MDR +9%. SOL +8%. NVDA +8%.
Losers: RNDY -11%. PBTH -11%. DAR -9%. JPM -8.5%. SNE -8%.
Comment!
[On the Move]

ATHX in Focus more »

Athersys Shares Poised To Move Higher

Wall Street Titan • Thu, Dec 1, 2011 • 10 Comments
Athersys MultiStem PI Data For Acute Myocardial Infarction

Henry McCusker • Mon, Nov 7, 2011 • 2 Comments
Athersys Q2 Loss Is Slight Improvement Over Previous Year

Henry McCusker • Thu, Aug 11, 2011 • Comment!
Athersys Releases Impressive 12 Month Heart Attack Data for MultiStem

Wall Street Titan • Fri, Jun 10, 2011 • 6 Comments
Athersys Releases Encouraging Results for Single Dose Arm of MultiStem

Wall Street Titan • Thu, May 26, 2011 • Comment!

ATHX Related Articles more »

6 High-Growth Biotech Stocks Analysts Rate As Buys

ZetaKap • Fri, May 18 • Comment!
NeoStem: Huge Potential In The Cell Therapy Sector

Joe Gantoss • Mon, Apr 30 • 5 Comments
Institutional 5% Ownership Filings Last Week By Leading Funds

Ganaxi Small Cap Movers • Tue, Dec 6, 2011 • Comment!
Big Pharma Slowly Enters Stem Cell Therapy Game

Brian Ganch • Fri, Nov 11, 2011 • 4 Comments
Post Excessive Sell-Off, September Is Still In The Wind

Henry McCusker • Tue, Aug 30, 2011 • Comment!
Regenerative Medicine Companies Trading At Huge Discounts

Henry McCusker • Wed, Aug 24, 2011 • 3 Comments
4 Biotech Companies That Could Be Buyout Targets

Investment Underground • Tue, Apr 5, 2011 • 8 Comments
Insider Buying: 5 Stocks With Significant CEO Purchases

Steven Kiel • Wed, Mar 30, 2011 • Comment!
Acorda Hopes to Meet Huge Need in Challenging Stroke Market

Douglas Cress • Thu, Oct 21, 2010 • Comment!
Stem Cell Competition Heating Up

Michael Becker • Wed, Aug 25, 2010 • 8 Comments

ATHX News more »

Biotech Report: Are stem-cell stocks a good buy?

at MarketWatch.com (Jul 13, 2011)
Stem-cell stocks rise on artificial-trachea report

at MarketWatch.com (Jul 8, 2011)
Biotech Stocks: SIGA tumbles as drug indexes fall

at MarketWatch.com (Nov 8, 2010)
Biotech Stocks: Chelsea rallies on drug data; sector indexes rise

at MarketWatch.com (Sep 20, 2010)
Stem-cell stocks regain ground

at MarketWatch.com (Aug 26, 2010)

ATHX Press Releases and Filings more »

Athersys Reports First Quarter 2012 Results

GlobeNewswire (May 14, 2012)
Athersys Announces Meeting With FDA to Discuss Advancing Clinical Development of MultiStem(R) for the Prevention of GvHD

GlobeNewswire (Apr 27, 2012)
Athersys to Host First Quarter 2012 Financial Results Call

GlobeNewswire (Apr 23, 2012)
Publication in Cell Transplantation Indicates That MultiStem(R) Could be Used in Treatment of Orphan Neurological Disorders

GlobeNewswire (Apr 20, 2012)
Athersys Receives U.S. Patent Covering the Suppression of Graft-versus-Host Disease Associated With Hematopoietic Stem Cell Transplantation With Adult Stem Cells

GlobeNewswire (Apr 4, 2012)

ATHX Latest Transcript more »

Athersys, Inc. Q3 2008 Earnings Call Transcript

Fri, Nov 28, 2008
Popular searches: clinical, multistem, athersys, third, phase, gil, additional, company, going, update.

Earlier ATHX transcripts

ATHX Cramer more »

Currently, there are no Cramer articles on ATHX.

ATHX Instablog posts more »

Athersys, Inc. (ATHX) Awarded Patent Protection for MultiStem Product Platform, adding to Current IP Portfolio

Wed, Jan 4 • MissionIR • Comment!
Athersys, Inc. (ATHX) Awarded Patent Protection for MultiStem Product Platform, adding to Current IP Portfolio

Wed, Jan 4 • QualityStocks • Comment!
Athersys Inc. (ATHX) Forms Alliance with National Multiple Sclerosis Society Subsidiary to Advance Candidate for MS Treatment

Fri, Oct 21, 2011 • MissionIR • Comment!
Athersys Inc. (ATHX) Forms Alliance with National Multiple Sclerosis Society Subsidiary to Advance Candidate for MS Treatment

Fri, Oct 21, 2011 • QualityStocks • Comment!
Athersys, Inc. (ATHX) Video Chart for Friday, August 26, 2011

Fri, Aug 26, 2011 • QualityStocks • Comment!

Write a post on ATHX

ATHX StockTalks

ATHX vs. ETF Alternatives

Company Description

Currently, there's no company description for ATHX.

Sector: Healthcare

Industry: Biotechnology

Country: United States